Our Workshops

We organize and sponsor international workshops to facilitate one of the key missions of the BioMed21 collaboration – to bring relevant players together in order to identify opportunities, acknowledge existing barriers, and make recommendations necessary for implementation of a human biology platform for biomedical research. Here you can learn about our events: the speakers, their presentations, and formal accounts of the workshops, including our published workshop reports.

UPCOMING EVENTS
We currently have no upcoming events.

PAST EVENTS

2024 – April

WEBINAR Taking the leap towards Microphysiological systems: The Role of Standards and Funding

Microphysiological systems (MPS) are capable of simulating critical features of human organ systems and have demonstrated great potential in revolutionizing drug testing and development. Despite this, barriers remain to the adoption of MPS across the globe.

BioMed21 partners, Humane Society International, Centre for Predictive Human Model Systems – CPHMS and STEMPeers, hosted a virtual webinar exploring the role of harmonised standards as a first step in building confidence in MPS, and how public and private funding programs can promote the development and use of these systems.

In the first part of the session, Dr Lorna Ewart (Emulate) and Dr Abhijit Majumder (Indian Institute of Technology, Bombay) lead discussions on the standardisation of microphysiological systems, taking the audience through case study examples of this process for their liver-on-a-chip and placenta-on-a-chip systems. Afterwards, there was a panel discussion with regulators, government stakeholders, and private funding bodies on how dedicated funding programs can accelerate the development of MPS.

The virtual webinar took place on 24^th April 2024.

Feel free to read our recently published article on the need for harmonizing global policies for microphysiological systems.

Agenda:

Introduction & pre-workshop survey (15 mins)
Standardisation: Case study discussions (30 mins)
Dr Lorna Ewart (Emulate): Liver on a chip
Dr Abhijit Majumder (Indian Institute of Technology, Bombay) : Placenta-on-a-chip [UL1] [UL2]
Panel discussion on how funding can accelerate the development of MPS (30 mins)
Conclusions & post-workshop survey (10 mins)

Session Chair:

Dr Y K Gupta, Chair Technical Committee Good Lab Practices; Vice Chair National Standing Committee on Medicine & Healthcare Products; President AIIMS Jammu, ex Dir CSIR-IIT

Panel members:

Dr Sonja Beken (Belgian Federal Agency for Medicines and Health Products (FAMHP)
Ms Rajeshwari Adheseshan (Bill and Melinda Gates Foundation)
Dr Glynn Stacey (Director, International Stem Cell Banking Initiative)
Mr. Vishal Gandhi (CEO, BIORx- Venture Capitalist)
Dr Dhiraj Kumar (Chief Manager (Health Care) at Biotechnology Industry Research Assistance Council, Department of Biotechnology, Govt. of India)

2021 – September

Alternatives to Animal Testing with Scientific Approaches
A biomedical research multi-stakeholder forum organized by the National Assembly and Humane Society International/Korea, Seoul, So. Korea

Agenda (English
Agenda (Korean)
Press Release (English)

Video (English- Full Length)
Video (English – 1 min)
Video (Korean – Full Length)

August 2020-March 2022
CPHMS Webinar Series: Developing Human Relevant Research in India

* Humane Society International, co-founder of the BioMed21 Collaboration, co-organized the webinar series.

Developing Human Relevant Research in India Part 11 – In – vitro humanized 3D bioprinted lung model

2021 – March
Online Symposium (Korea): 3D Tissue chip and MPS, from development to regulatory adaptation

Microphysiological systems – from scientific models towards industrial adaptation of qualified assays and their regulatory acceptance
Uwe Marx, CSO & Founder, TissUse, Germany

U.S. interagency OOC development program: from funding to qualification for regulatory acceptance
Suzanne Fitzpatrick, FDA, United States

Introducing new legislative effort, Act on the promotion of development, distribution and use of alternatives to animal testing
Borami Seo, Interim ED, Senior Policy Manager, Humane Society International, Korea

Industry’s role for OOC development and regulatory applications
Adrian Roth, Roche, Switzerland

2020 – June
National Assembly Forum to Discuss the Proposed Promotion of Alternatives to Animal Methods Act
National Assembly, Seoul, South Korea

2019 – May
BioMed21: Science Without Animal Use
National Assembly, Seoul, South Korea

2019 – April
Cosmetic Risk Assessment and Regulatory Application of Non-animal Testing Technology
Shanghai, China

2019 – March
Humane Society International Symposium on Global Harmonization of Vaccine Testing Requirements
Rome, Italy

2018 – November
National Conference on Alternatives to Animal Experiments
Jamia Hamdard, New Delhi, India

2018 – October
2nd Asian Congress on Alternatives*
Guangzhou, China

Agenda
BioMed21 presentation by Catherine Willett
AOP continuing education course
Press release
* Humane Society International, co-founder of the BioMed21 Collaboration, is a founding co-organizer and sponsor of the Asian Congress on Alternatives and of the annual Chinese Conferences on Toxicological Alternatives and Translational Toxicology.

2018 – June
China’s 8th Workshop on Alternative Methods*
Shanghai, China

Agenda
Presentations
* Humane Society International, co-founder of the BioMed21 Collaboration, co-sponsored China’s 8th Workshop on Alternative Methods

2017 – June
BioMed21: A Human Pathways Approach to Disease Research
National Institutes of Health, Bethesda, Maryland, United States

Agenda
Presentations
Flash report
Organizing Committee: Chris Austin (NCATS/NIH), Brian Berridge (GSK), Warren Casey (NIEHS/NIH), Suzy Fitzpatrick (FDA), Robert Kavlock (EPA), Troy Seidle (HSI), Anton Simeonov (NCATS/NIH), Dan Tagle (NCATS/NIH), Catherine Willett (HSUS/HSI)
Final report